Advancing patient care in the evolving prostate cancer treatment landscape (HYBRID) - European Medical Journal

Advancing patient care in the evolving prostate cancer treatment landscape (HYBRID)

Urology

This Bayer-sponsored symposium titled ‘Advancing patient care in the evolving prostate cancer treatment landscape (HYBRID)’ took place on 3rd July 2022 as part of the European Association of Urology 2022 (EAU22) in Amsterdam, the Netherlands.

The symposium and hosting of this video were funded by Bayer.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now